FIELD: pharmacology.
SUBSTANCE: claimed invention relates to novel antitumor compounds of kahalalide, in particular to analogues of kahalalide F, which are used as antitumor agents.
EFFECT: novel antitumor compounds.
13 cl, 6 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
KAHALALIDE F DERIVATIVES | 2004 |
|
RU2395520C2 |
KAHALALIDE COMPOUNDS | 2001 |
|
RU2280039C2 |
KAHALALIDE F | 2001 |
|
RU2292216C2 |
ANTICANCER DIHYDROPYRAN-3-ONE COMPOUNDS | 2007 |
|
RU2444519C2 |
ECTEINASCIDIN DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2283842C2 |
ANTI-CANCER STEROID LACTONES UNSATURATED IN POSITION 7(8) | 2011 |
|
RU2572595C2 |
ESTERS OF STEROID LACTAM AND DERIVATIVES OF BIS(2-CHLOROETHYL)AMINOPHENOXYPROPANOIC ACID | 2016 |
|
RU2719457C2 |
PYRIDINE COMPOUNDS OF PLADIENOLIDE AND METHODS OF THEIR USE | 2015 |
|
RU2807278C2 |
ANTITUMOUR COMPOUNDS | 2008 |
|
RU2493147C2 |
PYRIDINE COMPOUNDS OF PLADIENOLIDE AND METHODS OF USE | 2015 |
|
RU2707730C2 |
Authors
Dates
2009-05-27—Published
2003-10-20—Filed